Investigational Drug Targets Sleep Apnea and Nocturnal Hypertension
A phase 2 trial will evaluate the drug’s potential to reduce upper airway obstruction and nocturnal hypertension in patients with moderate-to-severe OSA.
Category: Uncategorized
Must-Read Insights
Staff's Top Picks
AMA Stands Firm on Affirmative Action: Recognizing the Importance of Diversity in Medical School Admissions
The American Medical Association adopts new policies emphasizing the significance of diversity in medical school admissions, amidst ongoing Supreme Court cases on affirmative action.